IRIS
LANINI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.829
NA - Nord America 660
SA - Sud America 546
EU - Europa 375
AF - Africa 26
OC - Oceania 2
Totale 3.438
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 865
US - Stati Uniti d'America 619
BR - Brasile 455
HK - Hong Kong 307
CN - Cina 272
VN - Vietnam 175
RU - Federazione Russa 109
IT - Italia 80
KR - Corea 79
GB - Regno Unito 35
AR - Argentina 32
DE - Germania 28
BD - Bangladesh 27
ID - Indonesia 25
NL - Olanda 24
MX - Messico 20
EC - Ecuador 18
IN - India 18
AT - Austria 15
FR - Francia 15
SE - Svezia 13
CA - Canada 11
IE - Irlanda 10
IQ - Iraq 10
CO - Colombia 9
ES - Italia 8
PY - Paraguay 8
UA - Ucraina 8
TR - Turchia 7
VE - Venezuela 7
ZA - Sudafrica 7
CL - Cile 6
JP - Giappone 6
PL - Polonia 6
UY - Uruguay 6
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
FI - Finlandia 4
MA - Marocco 4
PE - Perù 4
PK - Pakistan 4
DO - Repubblica Dominicana 3
IL - Israele 3
KE - Kenya 3
LV - Lettonia 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
SA - Arabia Saudita 2
TN - Tunisia 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.438
Salva come PNG Salva come JPEG
Città #
Singapore 404
Hong Kong 306
Ashburn 119
Beijing 111
Boardman 83
Hefei 79
Seoul 79
Ho Chi Minh City 59
Dallas 55
Los Angeles 45
Redondo Beach 38
Hanoi 33
Buffalo 31
São Paulo 29
Santa Clara 23
Rio de Janeiro 13
Amsterdam 12
New York 11
Stockholm 11
Dublin 10
Chennai 9
Da Nang 9
Guangzhou 9
Guayaquil 9
Atlanta 8
Udine 8
Vienna 8
Haiphong 7
Mexico City 7
Pelotas 7
Porto Alegre 7
Quito 7
Wuhan 7
Campinas 6
Curitiba 6
Dhaka 6
Düsseldorf 6
Frankfurt am Main 6
Jakarta 6
Lauterbourg 6
Montevideo 6
Nuremberg 6
The Dalles 6
Tokyo 6
Warsaw 6
Asunción 5
Belford Roxo 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Brooklyn 5
Chicago 5
Cuiabá 5
Denver 5
Feira de Santana 5
Ha Long 5
Milan 5
Ribeirão Preto 5
Shenzhen 5
São José dos Campos 5
Thái Bình 5
Belluno 4
Bologna 4
Dong Ket 4
Goiânia 4
Houston 4
Itaquaquecetuba 4
Joinville 4
London 4
Maceió 4
Manchester 4
Montreal 4
Mumbai 4
Osasco 4
Phủ Lý 4
Quảng Ninh 4
Thái Nguyên 4
Xi'an 4
Ankara 3
Athens 3
Bauru 3
Bogotá 3
Buenos Aires 3
Camden 3
Caxias do Sul 3
Falkenstein 3
Guarulhos 3
Islamabad 3
Jaboatão dos Guararapes 3
Johannesburg 3
Juiz de Fora 3
Lappeenranta 3
Limeira 3
Manaus 3
Natal 3
Phoenix 3
Pittsburgh 3
Praia Grande 3
Recife 3
Ribeirão das Neves 3
Totale 1.939
Salva come PNG Salva come JPEG
Nome #
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 106
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 71
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 67
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 66
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 65
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 61
Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission 56
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials 55
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital: USE OF ANTIVIRALS FOR MONKEYPOX IN AN ITALIAN HOSPITAL 55
Appropriateness of surgical antimicrobial prophylaxis in the Latium Region of Italy, 2008: A multicenter study 55
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians 52
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 50
A large epidemic of hepatitis B in Serbia: An integrated model for outbreak investigations in healthcare settings 50
Noninvasive positive-pressure ventilation 49
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study 48
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects 48
Temporal intra-host variability of mpox virus genomes in multiple body tissues 47
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH 46
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 45
Non-randomised Ebola trials-lessons for optimal outbreak research 45
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 44
The middle east respiratory syndrome coronavirus – a continuing risk to global health security 44
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 44
Author's reply: measles on a cruise ship--links with the outbreak in the Philippines 44
Risk of infection in patients with lymphoma receiving rituximab: Systematic review and meta-analysis 43
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis 42
Analysis of Diagnostic Findings from the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 42
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak 42
Infections in patients taking Rituximab for hematologic malignancies: Two-year cohort study 41
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 40
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser 40
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 40
Hepatitis C: global epidemiology and strategies for control 40
Cefepime-Taniborbactam in Complicated Urinary Tract Infection 40
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study 40
Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy 40
Liver transplant recipients and prioritization of anti-HCV therapy: An Italian cohort analysis 39
Ebola virus disease complicated with viral interstitial pneumonia: A case report 38
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results 38
Epidemiology of HEV in the mediterranean basin: 10-year prevalence in Italy 38
Viral hemorrhagic fevers: Advancing the level of treatment 38
Risk management of febrile respiratory illness in emergency departments 38
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen 38
Pulmonary involvement during the Ebola virus disease 38
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH 38
COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 38
Is hepatitis C virus eradication around the corner only 25 years after its discovery? 38
Blood kinetics of Ebola virus in survivors and nonsurvivors 38
Criteria for discharge of patients with Ebola virus diseases in high-income countries 37
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) 37
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 37
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 37
Local transmission of chikungunya in Rome and the lazio region, Italy 37
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 37
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: A nationwide surveillance study 37
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: Outbreak investigation and infection outcome 37
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) 37
Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome 36
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy 36
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 36
Reply to Reisler et al 36
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach 36
The surveillance of chikungunya virus in a temperate climate: Challenges and possible solutions from the experience of Lazio Region, Italy 35
The added value of long-lasting preparedness for the management of a patient with Ebola 35
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count 35
SELP Asp603Asn and severe thrombosis in COVID-19 males 35
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox 35
Influenza A (H1N1) in Rome, Italy in family: Three case reports 35
Short-term economic impact of the Zika virus outbreak 35
RE: Measles on the cruise ship: Links with virus spreading into an emergency department in southern Italy 35
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: Evidence from outbreak investigation 34
Ebola: Missed opportunities for Europe-Africa research 34
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 34
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV 34
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries 33
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 33
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 33
Relationship between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 32
Hospital cluster of HBV infection: Molecular evidence of patient-to-patient transmission through lancing device 32
Hepatitis C virus treatment revolution: Need for close monitoring 31
Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in sierra leone during the 2014–2016 outbreak in west Africa 31
Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection 31
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents 31
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves 30
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020 30
Measles cases during ebola outbreak, West Africa, 2013–2106 29
Hiv/hcv co-infection: Putting the pieces of the puzzle together 28
Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007 27
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 27
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 27
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? 26
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study) 26
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV 26
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease 14
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study 11
Totale 3.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 6 0 0 0 0 0 4
2021/20224 0 0 0 0 0 0 0 0 0 1 2 1
2022/20232 1 0 0 0 0 1 0 0 0 0 0 0
2023/20247 0 0 0 0 1 0 0 3 0 1 0 2
2024/20251.893 1 464 206 30 45 66 61 64 111 67 351 427
2025/20261.861 144 283 525 483 398 28 0 0 0 0 0 0
Totale 3.777